FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)

View source ↗

Summary

FDA supplemental application for ZOLADEX (goserelin) submitted by TerSera Therapeutics LLC, likely related to labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometriosis
• Precocious Puberty
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• Zoladex (goserelin)

Snippet

SUPPL AP for ZOLADEX (GOSERELIN)